Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VKTX
VKTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VKTX News
Viking Therapeutics Stock Potential Analysis
Jun 12 2026
Fool
Viking Therapeutics Advances in Weight Loss Drug Development
Jun 12 2026
NASDAQ.COM
Viking Therapeutics Appoints New Chief Medical Officer
Jun 11 2026
NASDAQ.COM
Viking Therapeutics Appoints New Chief Medical Officer
Jun 11 2026
PRnewswire
Viking Therapeutics Appoints New Chief Medical Officer
Jun 11 2026
Newsfilter
Analyst Optimistic on Viking Therapeutics' Future Potential
Jun 10 2026
Fool
Viking Therapeutics Targets $150 Billion Obesity Drug Market
Jun 10 2026
NASDAQ.COM
Buffett's Investment Strategy and Healthcare Opportunities
Jun 03 2026
Fool
Buffett and Abel's Investment Strategies
Jun 03 2026
NASDAQ.COM
Viking Therapeutics' VK2735 Phase 3 Trials Outlook
Jun 03 2026
NASDAQ.COM
Viking Therapeutics Faces Competitive Challenges in Weight-Loss Market
Jun 03 2026
Fool
Viking Therapeutics Faces Challenges and Opportunities Ahead
Jun 03 2026
stocktwits
Investment Case for Viking Therapeutics' VK2735 Weight-Loss Drug Development
Jun 02 2026
Fool
Is It Time to Reload Your Underinvested Portfolio?
May 30 2026
Fool
Analysis of Shopify's Stock Price Decline
May 30 2026
NASDAQ.COM
Truist Initiates Coverage on VKTX with Buy Rating and $83 Price Target
May 28 2026
stocktwits
Show More News
